Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-15-006514
Filing Date
2015-12-31
Accepted
2015-12-31 17:05:17
Documents
30
Period of Report
2015-02-28

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 220069
2 ex31-1.htm EX-31.1 14054
3 ex32-1.htm EX-32.1 8007
  Complete submission text file 0001493152-15-006514.txt   947696

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE ptlf-20150228.xml EX-101.INS 83694
5 XBRL SCHEMA FILE ptlf-20150228.xsd EX-101.SCH 11441
6 XBRL CALCULATION FILE ptlf-20150228_cal.xml EX-101.CAL 19351
7 XBRL DEFINITION FILE ptlf-20150228_def.xml EX-101.DEF 23926
8 XBRL LABEL FILE ptlf-20150228_lab.xml EX-101.LAB 91536
9 XBRL PRESENTATION FILE ptlf-20150228_pre.xml EX-101.PRE 65362
Mailing Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210
Business Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210 (310) 279-5152
PetLife Pharmaceuticals, Inc. (Filer) CIK: 0001354591 (see all company filings)

EIN.: 331133537 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52445 | Film No.: 151316196
SIC: 2860 Industrial Organic Chemicals